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still debated. Cancers originating less than 2 cm from
the carina or at the tracheobronchial angle offer an even
greater challenge.
To overcome the difficulty in resecting this kind of
tumor, Gibbon1 in 1959 devised a personal technique
and presented his first cases of tracheal sleeve pneu-
monectomies. A few other sporadic attempts by other
surgeons using different modified techniques were
reported in literature during the following years. In
1972 Jensik and coworkers2 presented the first con-
sistent series of 17 patients subjected to this tech-
nique; in 1982 the same authors3 updated the series to
34 patients, with a perioperative mortality of 29%.
Other authors subsequently reported limited personal
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therefore had not undergone video-assisted thoracoscopy),
thoracotomy showed involvement of the venae cavae in 3
patients and pleural carcinosis without effusion in the 3 other
patients.
Among 5 (8.3%) patients who had undergone operation
after 1993, video-assisted thoracoscopy in 2 patients showed
unsuspected pleural carcinosis without pleural effusion, thus
avoiding a useless exploratory thoracotomy. In the other 3
patients, video-assisted thoracoscopy could not be completed
because of diffuse adhesions, and thoracotomy showed the
inoperability of the lesion as a result of caval invasion in 2
patients and involvement of the pulmonary artery below the
vena cava in 1 patient. Therefore, 11 (18.3%) exploratory
operations were carried out because preoperative staging had
failed to show any evidence of inoperability.
Of the remaining patients, 48 had a right and 1 a left tra-
cheal sleeve pneumonectomy. All operations were performed
through a posterolateral thoracotomy in the fifth intercostal
space, because this approach is technically simpler and
ensures a more complete exposure of the carina and the entire
trachea than does sternotomy.
Fifteen patients also required intrapericardial dissection
and ligature of the pulmonary vessels. In no case was the
anastomosis covered with viable pedicled tissue.
Histologic examination of the specimens revealed 32
(65.3%) squamous cell carcinomas, 11 (22.5%) adenocarci-
nomas, 3 (6.1%) large cell carcinomas, 2 (4.1%) adenoid cys-
tic carcinomas, and 1 (2%) rare blastoma. If this last case of
blastoma is excluded, the cases were classified as 22 pT3 N0,
13 pT3 N1, and 12 pT3 N2 according to the American Joint
Committee on TNM staging. In 1 patient who had undergone
neoadjuvant chemotherapy for epidermoid carcinoma, histo-
logic examination could reveal no residual tumor (“complete
pathologic response”). Clinical TNM stage had been T3 N0
in 34 cases and T3 N2 in 14 cases.
Of the 49 patients subjected to tracheal sleeve pneumonec-
tomy, 27 (55.1%) did not receive preoperative neoadjuvant
treatment, 17 (34.6%) received low-dose (30 Gy) radiothera-
py according to the Paulson protocol,5 2 (4.1%) patients
received high-dose (60 Gy) radiotherapy, 2 (4.1%) patients
underwent chemotherapy, and 1 (2.1%) patient underwent
both chemotherapy and low-dose (30 Gy) radiotherapy.
Surgical technique. Our surgical technique has already
been thoroughly discussed in a previous work7; we will there-
fore merely outline the main points. Ventilation techniques
altered over time until 1987, when the present technique was
established. Since 1987 we have used the Sybilla Fome-Cuf
tube produced by Bivona, Inc (Gary, Ind), for ventilation,
which greatly facilitates all maneuvers. This is a slender, sil-
icone-reinforced tube, 5 to 6.5 mm in diameter and 45 cm in
length, with a small, self-inflating polyurethane foam cuff
located 1.5 cm from the tip. General anesthesia is induced
and the patient is intubated with a double-lumen Carlens
tube. Once the thoracic cavity is open, the distal trachea and
carina are mobilized. Two traction threads are placed around
the trachea and left main bronchus; the anterior aspect of the
trachea is then delicately isolated for a distance of 4 to 5 cm.
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experiences with a perioperative mortality reaching
31%.4-6 However, the series were not easily compara-
ble because they extended over long periods, with
differing patient selections and surgical techniques.
In the January 1994 issue of this Journal, we7
reported a series of 28 tracheal sleeve pneumonec-
tomies that aroused much interest because of the very
low mortality and the absence of anastomotic com-
plications. We had in fact recorded only 1 death from
myocardial infarction on the thirtieth postoperative
day and no cases of stenosis or dehiscence. We
received many questions regarding specific technical
details such as the tracheobronchial anastomosis,
anesthesia, and the preoperative and postoperative
management of our patients. Since then we have
recorded 3 more deaths, which brought our total peri-
operative mortality to 8.2%, and other postoperative
complications. This encouraged us to carry out an
accurate revision of literature. We have therefore con-
sidered all series presented in the literature since
19858-17 having been carried out by the same surgical
team or by similar operative techniques. Results were
compared with our series of 49 tracheal sleeve pneu-
monectomies that were accomplished over a 16-year
period. Even considering these criteria, an accurate
evaluation of the complications specifically pertinent
to tracheal sleeve pneumonectomies as compared
with global tracheobronchial resections was some-
times difficult.
Patients and methods
From 1983 to September 1999, we treated 89 patients who
had lung cancer arising less than 2 cm from the carina or infil-
trating the tracheobronchial angle and who therefore were
candidates for a tracheal sleeve pneumonectomy. All patients
were subjected to routine preoperative staging: total body
computed tomography, bone scintigraphy, bronchoscopy, and
pulmonary function tests. Mediastinoscopy is not routinely
performed for all patients with lung cancer.
Since 1993, all patients with lung cancer at any stage that
is deemed operable are subjected to thoracoscopy as the first
step of the operation, before thoracotomy, to reveal causes of
inoperability undetected by common staging procedures.18
The same strategy is applied also for candidates for tracheal
sleeve pneumonectomy.
Of 89 patients, 29 (32.5%) were considered to have inoper-
able disease after conventional preoperative staging, specifi-
cally because of extracapsular subcarinal mediastinal lymph-
adenopathy in 13 (14.6%) cases, evident mediastinal invasion
in 8 (8.9%) cases, and distant metastases in 8 (8.9%) cases.
Sixty (67.4%) patients were judged to have operable dis-
ease on the basis of conventional preoperative staging and
underwent operation. In 6 (10% of all surgically treated
patients) who had been referred to us before 1993 (and who
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At this point the left main bronchus is severed at the second
bronchial ring, intubated, and transiently ventilated from the
operative field with a 6-mm Portex tube (Concord/Portex,
Keene, NH). Pneumonectomy and resection of the carina are
then carried out, and a stiff lead is inserted through the
Carlens tube from the operative field. The anesthetist can
then withdraw the Carlens tube and replace it with a Sybilla
tube, which can then easily be positioned in the left main
bronchus by the surgeon. The anastomosis is then created by
placing interrupted stitches knotted on the outer side of the
bronchus with a 3-0 polyglactin-intertwined thread (Vicryl;
Ethicon, Inc, Somerville, NJ). The stitches are positioned
about 2 mm apart on the bronchus and about 3 mm apart on
the trachea, starting from the deeper ones. Once the suture
has been completed, the ventilation tube is withdrawn above
the anastomosis and a hydropneumatic test is carried out. No
further maneuvers for mobilizing the hilum are necessary,
and we do not cover the anastomosis with viable tissue.
Lymphadenectomy of carinal, paracaval, and paratracheal
lymph nodes is accurately performed routinely. The patient is
usually extubated in the operating room after bronchoscopic
evaluation of the anastomosis and vocal chord mobility. The
mean operative time is 160 minutes. During the anastomosis,
single-lung ventilation pressure ranges between 20 and 25
mm Hg with an oxygen tension of 80%. Tidal volume ranges
between 550 and 650 mL with a mean rate regulated accord-
ing to the arterial oxygen saturation and carbon dioxide ten-
sion. During the operation 1500 mL of fluid is administered.
Halfway through the procedure, 1.5 mg of betamethasone
and 20 mg of furosemide are administered (the latter regard-
less of blood pressure alterations). Both doses can be repeat-
ed at the end of the operation.
During the postoperative course, the patient’s cervical
spine is kept in the normal position without flexing the neck.
Results
No intraoperative deaths occurred, although there were 4
perioperative deaths (8.2%) (Table I). One patient died of
myocardial infarction on the twenty-second postoperative
day, and another patient died of heart failure due to dilated
cardiomyopathy on the eighth postoperative day. The 2 other
patients had both been subjected to high-dose (60 Gy) radio-
therapy and died of noncardiogenic pulmonary edema on the
second postoperative day and of gastric ulcer hemorrhage on
the twenty-second postoperative day, respectively. In this last
case, clinical and radiologic signs of bronchial fistula had
appeared on the ninth postoperative day, and bronchoscopy
had shown a small fistula on the right edge of the anastomo-
sis, but no sign of respiratory distress had been present.
Major perioperative complications were encountered in 5
(10.2%) other patients. One patient had a noncardiogenic
lung edema that resolved after tracheotomy and assisted ven-
tilation for 3 months. Dysphonia resulting from transient
paresis of the recurrent nerve after extended mediastinal
lymphadenectomy was experienced by 2 patients and
resolved within 4 months. One patient had an empyema 1
month postoperatively, but there was no evidence of bron-
chopleural fistula and the empyema resolved with conserva-
tive treatment. One last patient had pneumonia that resolved
with antibiotic treatment.
Minor and unspecific complications that did not require
treatment are not described. We have not encountered any
instances of late stenosis of the anastomosis.
At follow-up, 26 patients (53%) are alive and free of dis-
ease 14 to 87 months postoperatively, 12 (24.5%) of these
more than 5 years postoperatively. Five (10.2%) patients died
of mediastinal recurrence and 16 (32.7%) of distant metas-
tases between 6 and 54 months after the operation. Two
(4.1%) other patients died of unrelated causes—traffic acci-
dents—13 and 42 months postoperatively.
Discussion
Tracheal sleeve pneumonectomy is an aggressive
procedure for resecting bronchial carcinomas involving
the tracheobronchial angle, carina, or lower trachea.
We now perform tracheal sleeve pneumonectomy in all
non–small cell lung cancers invading the main
bronchus that are less than 2 cm distal to the carina or
that arise at the tracheobronchial angle and extend
along no more than 3 cartilaginous rings on the distal
tracheal wall.
The operation is almost exclusively performed on the
right side because tumors on the left side rarely meet
the correct criteria for tracheal sleeve pneumonectomy.
As a matter of fact, tumors of the left main stem
bronchus almost always invade the structures of the
subaortic space. Furthermore, left tracheal sleeve pneu-
monectomy is a much more complicated and demand-
ing procedure with a greater occurrence of postopera-
tive complications. Indications for left tracheal sleeve
pneumonectomy remain exceptional and limited to
young patients with a low degree of malignancy who
therefore have a good chance of survival. Reports of
left tracheal sleeve pneumonectomy in the literature are
rare in comparison with the total number of tracheal
sleeve pneumonectomies.19,20
Table I. Personal experience with complications after
49 tracheal sleeve pneumonectomies (48 right and 1
left tracheal sleeve pneumonectomies)
No. of cases Rate 
Periop mortality 4 8.2%
Global incidence of complications 9 18.3%
Early respiratory failure 2 (1 periop death) 4.1%
Cardiac events 2 (2 periop deaths) 4.1%
Bronchopleural fistula 1 2%
Digestive tract bleeding 1 (1 periop death) 2%
Empyema 1 2%
Contralateral pneumonia 1 2%
Recurrent nerve paralysis 2 4.1%
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In very selected patients who cannot tolerate a tra-
cheal sleeve pneumonectomy, alternative procedures
such as tracheal sleeve lobectomy and reimplantation
of the intermediate bronchus on the left main stem
bronchus can be considered but imply a great number
of vascular and anastomotic complications.
In our opinion, the presence of intracapsular medi-
astinal N2 lymphadenopathy does not represent a con-
traindication, just as it does not for conventional pneu-
monectomy.21,22 For this reason we do not perform
routine mediastinoscopy. Mediastinoscopy is per-
formed only when N3 disease is suspected. When N2
disease is preoperatively documented, induction thera-
py is administered.
Since 1993, we have routinely performed explorato-
ry video-assisted thoracoscopy as the very first step of
the planned operation.
The consequences regarding respiratory function do
not differ from those associated with a standard pneu-
monectomy. The operation is characterized by the
reconstruction phase, during which the lower trachea is
anastomosed to the remaining main stem bronchus. The
technique has been refined progressively, and the whole
procedure can now be considered well defined and
standard. Like most authors,10,14,17 we use thin,
absorbable interrupted stitches for the tracheobronchial
anastomosis (3-0 Vicryl thread). A few authors14,16,17
protect the anastomosis with a pleural or pericardial
flap, but we have never used this technique. Even
though minor technical details can vary, placing a cor-
rect suture with the most meticulous surgical precision
is of paramount importance in limiting subsequent
complications at the anastomosis and ensuring a lasting
outcome.
The most recent series (later than 1985)8-14,16,17 do
not record any operative mortality during tracheal
sleeve pneumonectomy operations. The perioperative
mortality ranges between 10% and 29%; however, the
time span considered is 1 or 2 months postoperatively
according to different authors and is therefore very
inhomogeneous (Table II).
These data do not differ from those reported in the
literature for conventional pneumonectomy. After a
conventional pneumonectomy for lung carcinoma, the
perioperative rates considered on a 30 day-basis range
between 5% to 15% but can be as high as 30% for
patients 70 years of age or older.23,24 The recent review
of the literature by Klemperer and Ginsberg23 quoted
data from Romano and Mark,25 who reported mortality
ranging between 0% and 25%.
A review of the literature (Tables II and III) indicates
the main causes of perioperative mortality to be non-
cardiogenic pulmonary edema with ensuing acute res-
piratory failure (variously defined as acute respiratory
distress syndrome, early respiratory failure, and non-
cardiogenic pulmonary edema) and complications
deriving from the anastomosis. Other infrequent com-
plications such as contralateral pneumonia, cardiovas-
Table II
First author Operative mortality No. of deaths/cause of death Rate
Deslauriers12 (1989) 29% (11/38) 6: Early respiratory failure 54.5% (6/11)
5: Not specified
Tsuchiya16 (1990): 15 TSPs 
out of 20 resections of carina 15% (3/20) 1: Pneumonia 33.3% (1/3)
1: Mallory-Weiss tear 33.3% (1/3)
1: Unknown
Watanabe17 (1990) 17% (2/12) 1: Dehiscence of anastomosis 50% (1/2)
1: Stroke 50% (1/2)
Mathisen14 (1991): 21 TSPs and 
2 carina plus pneumonectomy 
stump resections out of 37  
resections of carina 8% (3/37) 3: Early respiratory failure 
(all during TSP) 100% (3/3)
Dartevelle9 (1995) 7.2% (4/55) 2: Bronchopleural fistula 50% (2/4)
2: Early respiratory failure 50% (2/4)
Roviaro (2000) 8.2% (4/49) 1: Early respiratory failure 25% (1/4)
1: Digestive tract bleeding with 
bronchopleural fistula 25% (1/4)
2: Cardiologic 50% (2/4)
TSP, Tracheal sleeve pneumonectomy.
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cular complications, and digestive tract bleeding are
also reported in the literature. 
Acute respiratory failure is reported to be as high as
22% in the literature11 and is characterized by a 50% to
100% mortality. In our experience, acute respiratory
failure occurred in 2 (4%) cases. One patient had
uncontrollable bronchorrhea and died on the second
postoperative day; the second patient required assisted
ventilation for 3 months but recovered. As reported by
all the authors and corroborated by our experience,
acute respiratory failure normally developed within 24
to 72 hours after the operation, with diffuse interstitial
infiltration insidiously making its appearance in the
remaining lung. Notwithstanding aggressive treatment
with diuretics, antibiotics, corticosteroids, regular
bronchoscopic cleansing of the trachea and bronchi,
and even assisted ventilation, respiratory failure pro-
gressively develops and can lead to death within a few
days. At autopsy, intense congestion of the lung with
no apparent cause is invariably present. Several
authors26,27 have suggested that the resection of all
afferent and efferent nerve pathways and the damage to
the mediastinal lymphatic system after mobilization of
the lung during the operation give rise to malfunction
of epithelial clearance mechanisms, mediastinal shift-
ing, pulmonary hypertension, and left ventricular fail-
ure. Acute respiratory failure is an event that cannot be
foreseen at present. However, scrupulous and repeated
bronchoscopic cleansing of bronchial secretions is of
paramount importance. Even more important is an
accurate water and solute balance; the patient’s fluid
intake must be cautiously limited to a bare minimum
during the operation and the immediate postoperative
period, such as 1500 mL during the first day and grad-
ual resumption of food on the second day. Intrathoracic
pressure of the pleural cavity of the resected side must
be maintained between –2 and –8 mm Hg by thoracen-
tesis. Acute respiratory failure seems not to be attrib-
uted to technical surgical mistakes.
Another fearsome complication is pleural empyema,
which can occur with or without a bronchopleural fistu-
la. Tracheal sleeve pneumonectomy can be functionally
defined as a pneumonectomy characterized by the pres-
ence of an anastomosis instead of a suture on the
bronchial stump. Despite current prophylaxis regimens
and the constant improvement of operative techniques,
pleural empyema is reported in the literature to occur at
a rate of 1% to 4%23,24 after pneumonectomy for malig-
nancy and a rate of 5% to 8% after tracheal sleeve pneu-
monectomy.8,15 In our experience, empyema occurred in
1 (2%) case and therefore equals the postpneumonecto-
my rate reported in literature. The persistence of a pleur-
al empyema that has not been immediately and ade-
quately drained determines an extremely high risk of
seepage through the bronchial stump or through the
suture rim, with ensuing secondary fistulization.
Table III
First author No. of patients/nonlethal complications Rate
Tsuchiya16 (1990): 15 TSPs out of 20 
resections of carina 3: Abnormal swallowing 15% (3/20)
2: Bronchopulmonary fistula 10% (2/20)
1: Candida tracheitis 5% (1/20)
1: Stenosis 5% (1/20)
1: Bronchial rupture during operation 5% (1/20)
Watanabe17 (1990) 1: Dehiscence of anastomosis 8.3% (1/12)
1: Aspiration pneumonia 8.3% (1/12)
Mathisen14 (1991): 21 TSPs and 2 carina plus 
pneumonectomy stump resections out of 37 
resections of carina 5: Pneumonia 13.5% (5/37)
9: Atrial fibrillation 24.3% (9/37)
4: Anastomotic stenosis 10.8% (4/37)
3: Anastomotic separation 8.1% (3/37)
3: Left vocal cord dysfunction 8.1% (3/37)
Dartevelle9 (1995) 1: Bronchopleural fistula 1.8% (1/55)
1: Early respiratory failure 1.8% (1/55)
4: Hemothorax 7.2% (4/55)
Roviaro (2000) 1: Early respiratory failure 2% (1/49)
1: Empyema 2% (1/49)
1: Contralateral pneumonia 2% (1/49)
2: Transitory recurrent nerve paralysis 4.1% (2/49)
The Journal of Thoracic and
Cardiovascular Surgery
Volume 121, Number 2
Roviaro et al 239
Conversely, a pleural empyema can itself be due to an
anastomotic fistula. Factors traditionally considered to
be responsible for the development of a fistula in case
of pneumonectomy are inflammation or malignant
infiltration of the bronchial stump, excessive dissection
of the stump that compromises its blood supply, inac-
curate suturing techniques, excessive length of the
bronchial stump, and preoperative radiotherapy.
Fistulization is still considered to be a dreadful compli-
cation and is difficult to control. According to the liter-
ature, fistulization occurs at a rate of 5% to 10%8,24
after tracheal sleeve pneumonectomy compared with
the slightly lower rate (1%-4%) reported after conven-
tional pneumonectomy.24 The tracheobronchial anasto-
mosis therefore appears to determine a higher risk of
fistulization; this could be due to a greater risk of com-
promising the blood supply determined by tracheal
mobilization and dissection maneuvers, even when the
classic procedures described by Grillo and associ-
ates28,29 are followed.
Cardiovascular complications such as myocardial
infarction, heart failure, and serious conduction disor-
ders are a further cause of perioperative mortality after
tracheal sleeve pneumonectomy; the incidence reported
in the literature reaches 19.8% of cases in some
series.15 The incidence of cardiovascular complications
reported in the literature is equal to that after conven-
tional pneumonectomy. The same is true for pneumonia
of the residual lung (15.4%).15 Surprisingly, digestive
tract bleeding represented a significant percentage of
complications in a number of series, including our own
(between 1.8% and 6.6%)8,16 with a mortality rate of
100%.
Preoperative radiotherapy, particularly high-dose
radiotherapy, is considered a major determinant of
postoperative complications. According to several
authors,8,12 preoperative radiotherapy should be avoid-
ed because of the higher risk of postoperative compli-
cations and mortality. In our experience, no increased
incidence of complications was observed in patients
who had undergone low-dose (30 Gy) preoperative
radiotherapy according to the Paulson protocol5 com-
pared with patients who had not undergone radiothera-
py. However, the 2 patients who had undergone high-
dose (60 Gy) preoperative radiotherapy had serious
complications that led to death in the immediate post-
operative period in both instances. The first patient had
had a high-dose (60 Gy) treatment. Evaluation after
radiotherapy had shown a good result, and the patient
had therefore undergone tracheal sleeve pneumonecto-
my. His postoperative course had been uneventful until
the ninth day, when clinical and x-ray evidence of fis-
tulization developed. A small bronchial fistula was
found on the right edge of the suture. A tracheostomy
was then carried out and the patient was intubated with
a Sybilla tube (the same tube we use for carrying out
the anastomosis) by inflating the balloon distal to the
anastomosis. The pleural cavity was then drained, but
during the following days repeated bronchoscopic
examinations showed no appearance of granulation tis-
sue or other signs of healing on the anastomosis. The
patient died on the twenty-second postoperative day of
a fatal hemorrhage from a gastric ulcer.
In the second patient (a 71-year-old man), a high-
dose (60 Gy) treatment had determined a marked
reduction of the tumor mass. Because we were still
uncertain about the role of high-dose radiotherapy in
facilitating dehiscence of the suture in the previous
case, and in consideration of the patient’s good general
condition, we decided to proceed to a tracheal sleeve
pneumonectomy. Severe bronchorrhea developed on
the first postoperative day necessitating repeated bron-
choscopic cleansing, which always showed a normal
appearing tracheobronchial anastomosis. The patient
died on the eighth postoperative day of pulmonary
edema. Now we strongly recommend that preoperative
radiotherapy be limited to 30 Gy.
Conclusions
Tracheal sleeve pneumonectomy is usually consid-
ered a technically extremely demanding operation
characterized by a high risk of complications. It is per-
formed in only a few centers worldwide with limited
series. However, a review of current literature and our
Table IV. Mortality and 5-year survivals after tracheal sleeve pneumonectomy for bronchogenic carcinoma
First author (dates) No. of cases Operative mortality (%) Five-year survival (%)
Deslauriers12 (1989) 38 (1968-1987) 29 13
Tsuchiya16 (1990) 20 (1977-1989) 15 59 (at 2 y)
Watanabe17 (1990) 12 (1975-1990) 17 Not reported
Mathisen14 (1991) 37 (1973-1991) 8 19
Dartevelle9 (1995) 55 (1981-1995) 7.2 40
Roviaro (2000) 49 (1983-1999) 8.2 24.5
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experience indicate that this concept must be overcome
(Table IV). Surgical and anastomotic techniques, even
though complex, are now perfectly defined. In the
hands of experienced teams, postoperative morbidity
and mortality rate do not differ from those after con-
ventional pneumonectomy. Accurate selection of
patients, a meticulous adherence to surgical precision,
and optimal postoperative patient care are mandatory to
reduce the risk of the most serious complications, such
as noncardiogenic pulmonary edema and suture dehis-
cence. However, these complications are not specific to
tracheal sleeve pneumonectomy and do not appear to
be directly attributable to inadequacy of surgical or
anesthesiology techniques.
The role of neoadjuvant therapy is still debated.
However, in our experience, when neoadjuvant therapy
is administered at a correct dosage it does not appear to
alter the operative course or increase the risk of com-
plications.
At present, tracheal sleeve pneumonectomy is the
only concrete treatment for tumors that originate at the
tracheobronchial angle and must be considered in every
patient who is a candidate. In experienced hands, long-
term survival after tracheal sleeve pneumonectomy is
equal to survival after pneumonectomy for locally
advanced tumors and shares the same prognostic fac-
tors.10,17,30
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